MBXC-4522
MBXC-4522 is an RVFV-EndoN inhibitor with an IC50 of 2.8 μM. MBXC-4522 exhibits antiviral activity. MBXC-4522 binds to and stabilizes the RVFV endonuclease through a metal-independent mechanism, inhibiting its activity and thereby blocking the viral "cap-snatching" mechanism. MBXC-4522 can be used for research on Rift Valley fever virus infection.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1340680-75-2
- 화학식: C23H29N5O2S
- 분자량:439.57
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | CC50 |
30.1 μM
|
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
|
40787859 |
| HepG2 | CC50 |
73.8 μM
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
|
40787859 |
| Vero | CC50 |
45.0 μM
|
Cytotoxicity against african green monkey Vero cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
Cytotoxicity against african green monkey Vero cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
|
40787859 |
| BV-2 | CC50 |
43.0 μM
|
Cytotoxicity against mouse BV2 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
Cytotoxicity against mouse BV2 cells assessed as reduction in cell viability by CellTiter Glo 2.0 assay.
|
40787859 |
In Vitro
MBXC-4522 (5-50 μM; 16 h) significantly inhibits RVFV-MP12GFP attenuated virus infection in BV2 cells[1].
MBXC-4522 inhibits purified RVFV-EndoN endonuclease activity in a dose-dependent manner, with an IC50 of 2.8 μM[1].
MBXC-4522 (5-50 μM; 18 h) inhibits RVFV (ZH501), SFTSV, and HRTV viral antigen expression, plaque formation, and reduces viral RNA levels in Vero E6 cells[1].
MBXC-4522 (0.1-100 μM; 72 h) exhibits dose-dependent cytotoxicity with low cytotoxicity in HEK293 (CC50 = 30.1 µM), HepG2 (CC50 = 73.8 µM), Vero (CC50 = 45.0 µM), and BV2 (CC50 = 43.0 µM) cell lines[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK293, HepG2, Vero6, BV2
-
Concentration:0.01, 0.03, 0.1, 0.3, 1, 3, 10, 30, 100 μM
-
Incubation Time:72 h
-
Result:Exhibited CC50 values of 30.1 μM in HEK293 cells, 73.8 μM in HepG2 cells, 45.0 μM in Vero6 cells, and 43.0 μM in BV2 cells.
Chemical Information
-
CAS No. 1340680-75-2
-
분자량 439.57
-
화학식 C23H29N5O2S
-
SMILES
O=S(C1=C(C)C=CC=C1)(N2CC3(NC4=CC=CN=C4N=C3NC5CCCC5)CCC2)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)